Text Box: SCP-1 and SCP-123 — Innovations for the Analgesic Market: More potent than NSAIDs Non-narcotic Not a COX inhibitor Low acute toxicity Long duration of action Rapid onset of analgesia Pre-emptive and neuropathic pain efficacy Parenteral OR oral dosage forms

Current Pipeline: Pain and Neuro-Inflammation